Unitedhealth Group INC 10-Q quarterly reports

UnitedHealth Group's Q2 2026 results show a significant increase in earnings and operating income, driven by strong performance across its segments, despite slight declines in membership.

UnitedHealth Group reported steady Q1 2026 revenues with a 2% increase, driven by UnitedHealthcare's pricing and Optum Rx growth, though earnings from operations saw a slight dip due to segment performance and strategic investments.

UnitedHealth Group reported a 50% decline in third-quarter operating earnings and a 61% drop in net earnings attributable to common shareholders, primarily due to elevated medical cost trends and Medicare funding reductions.

UnitedHealth Group reports strong Q2 2025 revenue growth driven by Medicare Advantage and Optum Rx, despite elevated medical costs and funding pressures impacting earnings.

UnitedHealth Group's Q1 2025 results show revenue growth driven by UnitedHealthcare and Optum, with earnings impacted by Medicare Advantage funding and elevated care patterns.

UnitedHealth Group's third-quarter results show revenue growth offset by increased medical costs and significant losses from divestitures, alongside ongoing impacts from a major cyberattack.

UnitedHealth Group's second-quarter earnings were impacted by a cyberattack and losses from the sale of South American operations, despite revenue growth in key segments.

UnitedHealth Group reported a net loss for the first quarter of 2024, impacted by a cyberattack on Change Healthcare and the sale of its Brazil operations.